Zprávy a Události

Farmaceutický svět se neustále vyvíjí, proto i my vnímáme jako důležité být informován. Zde Vám nabízíme přehled o všech novinkách a aktivitách společnosti Quinta, společně s dalšími odbornými zprávami z naší společnosti.

  • 19 prosince 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 prosince 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.

  • 3 října 2023

    Meet us at the heart of Pharma, CPHI 2023

    Quinta-Analytica is attending CPHI 2023 in Barcelona

  • 18 července 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 června 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Ekolab And Conscio Group Join Forces

    Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.

  • 6 dubna 2023

    Transdermal Patches, Films and Topicals – Putting the Skin in the Game

    Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.

  • 23 března 2023

    Clinical Tips – Benefits of Sequential Designs in Bioequivalence Studies

    Discover the power of sequential designs for bioequivalence studies, a crucial step in generics development: Their practical implementation, statistical analysis, and the well-being of the volunteers.

  • 23 března 2023

    A Prescription Against EU Medicine Shortages – Outsourcing Stabilities

    We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.

  • 27 ledna 2023

    Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions

    Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica.

  • 5 ledna 2023

    From Houston to Munich – Innovation & Compounding

    Pharma innovators often outsource demanding projects to specialist CROs. Gus Bassani of US-based PCCA and Markus Dachtler of Conscio's German subsidiary Gen-Plus, share lessons from their collaboration.

  • 7 prosince 2022

    Quinta’s Another Two Successful FDA Inspections

    We at Quinta-Analytica are proud to announce the successful completion of not 1 but 2 FDA inspections at our Prague and Brno sites. Thanks for your trust and support!

  • 24 listopadu 2022

    The Secret Behind 25 Years of Excellence

    Quinta-Analytica's 25th Anniversary give us the chance to look back at our successful trajectory of proactiveness, technical expertise and improvement in the company of Dr Miroslav Ryska, mass spectrometry expert and founder of Quinta.

  • 24 listopadu 2022

    Quinta-Analytica + Olga Havel Foundation – Helping to Help Others

    We are proud to announce that Quinta-Analytica has donated 100,000 CZK to the Olga Havel Foundation for the support of six families with members in need of neurorehabilitation.

  • 24 listopadu 2022

    Nitrosamine Analogues: Stepping up to a new Challenge

    Have you heard about Nitrosamine Analogues? Did you know even if a tested API is free of nitrosamine analogues, its related drug product may still contain high amounts of these new impurities? Keep reading to learn more!

  • 24 listopadu 2022

    New Stability Models for Faster & Better Shelf Life Estimations

    Are you a pharma company in need of stability testing but have just too many candidates to screen with conventional ICH assays? We at Quinta-Analytica can offer you accurate stability data 3 times faster than usual! Find out more below.

  • 24 listopadu 2022

    CPHI Frankfurt 2022: See you there!

    Quinta-Analytica is attending CPHI 2022 in Frankfurt

  • 24 listopadu 2022

    Clinical Tips: Linear & non-linear PK

    QUINTA is well-known for its state-of-the-art equipment and facilities used to perform clinical trials and bioanalytical services under GCP/GLP; but today our experts wish to talk about pharmacokinetics and statistical evaluations, an important part of their day to day work which doesn't always get the attention it deserves. Click and keep reading!

  • 24 listopadu 2022

    Clinical Tips: Intra- and Inter-subject Variability

    Interested in clinical study design? Today's Clinical Tips series focuses on intra- and inter-subject variability, crucial concepts for the correct calculation of sample size.